TreeWAS
Download association data
for this variant in csv format
Share this page

Variant-specific associations

rs12639288
log Bayes Factor = <0.0001
Chromosome 3   position 167,661,136  (GRCh37) Explore rs12639288 on Ensembl!
Variant rs12639288 is listed in the   GWAS Catalog  

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)

Hierarchical visualisation How to interpret this figure?
Associations at terminal nodes are shown if p(effect) ≥
Click here to show this figure without filtering.
Click on a node to zoom (except terminal nodes).
Download this figure in format
Results table
Term Risk
posterior probability
No effect
posterior probability
Protective
posterior probability
 
G91.9 Hydrocephalus, unspecified
0.056 0.944 0.000
G91 Hydrocephalus
0.043 0.957 0.000
G91.0 Communicating hydrocephalus
0.037 0.963 0.000
G91.1 Obstructive hydrocephalus
0.036 0.963 0.000
G91.8 Other hydrocephalus
0.035 0.965 0.000
G91.3 Posttraumatic hydrocephalus, unspecified
0.031 0.969 0.000
G91.2 Normal-pressure hydrocephalus
0.027 0.973 0.000
R53 Malaise and fatigue
0.000 0.987 0.013
Y42.7 Androgens and anabolic congeners
0.012 0.988 0.000
G25.8 Other specified extrapyramidal and movement disorders
0.010 0.990 0.000
R61.9 Hyperhidrosis, unspecified
0.000 0.992 0.008
C81.9 Hodgkin's disease, unspecified
0.000 0.992 0.007
C81 Hodgkin's disease
0.000 0.993 0.007
C81.1 Nodular sclerosis
0.000 0.993 0.007
H26.4 After-cataract
0.000 0.994 0.006
Z88.3 Personal history of allergy to other anti-infective agents
0.000 0.994 0.006
N39.8 Other specified disorders of urinary system
0.000 0.994 0.006
C81.0 Lymphocytic predominance
0.000 0.994 0.006
H90.1 Conductive hearing loss, unilateral with unrestricted hearing on the contralateral side
0.000 0.994 0.006
H34.8 Other retinal vascular occlusions
0.006 0.994 0.000
M15.1 Heberden's nodes (with arthropathy)
0.006 0.994 0.000
C81.2 Mixed cellularity
0.000 0.995 0.005
C81.7 Other Hodgkin's disease
0.000 0.995 0.005
C81.4 Lymphocyte-rich classical Hodgkin lymphoma
0.000 0.995 0.005
C81.3 Lymphocytic depletion
0.000 0.995 0.005
M15 Polyarthrosis
0.005 0.995 0.000
M15.2 Bouchard's nodes (with arthropathy)
0.004 0.996 0.000
Z93.1 Gastrostomy status
0.004 0.996 0.000
H90 Conductive and sensorineural hearing loss
0.000 0.996 0.004
H90.3 Sensorineural hearing loss, bilateral
0.000 0.996 0.004
G63.2 Diabetic polyneuropathy
0.000 0.996 0.004
M15.8 Other polyarthrosis
0.004 0.996 0.000
M15.9 Polyarthrosis, unspecified
0.004 0.996 0.000
H90.0 Conductive hearing loss, bilateral
0.000 0.996 0.004
M15.3 Secondary multiple arthrosis
0.004 0.996 0.000
C71.3 Parietal lobe
0.004 0.996 0.000
M15.4 Erosive (osteo)arthrosis
0.003 0.996 0.000
M15.0 Primary generalised (osteo)arthrosis
0.003 0.996 0.000
D33.2 Brain, unspecified
0.003 0.996 0.000
H90.6 Mixed conductive and sensorineural hearing loss, bilateral
0.000 0.996 0.003
H90.4 Sensorineural hearing loss, unilateral with unrestricted hearing on the contralateral side
0.000 0.997 0.003
M15.99 Polyosteoarthritis, unspecified
0.003 0.997 0.000
G96.0 Cerebrospinal fluid leak
0.003 0.997 0.000
H90.7 Mixed conductive and sensorineural hearing loss, unilateral with unrestricted hearing on the contralateral side
0.000 0.997 0.003
Q61.3 Polycystic kidney, unspecified
0.003 0.997 0.000
C92.1 Chronic myeloid leukaemia
0.000 0.997 0.003
H34 Retinal vascular occlusions
0.003 0.997 0.000
H90.2 Conductive hearing loss, unspecified
0.000 0.997 0.003
G50.0 Trigeminal neuralgia
0.000 0.997 0.003
C71 Malignant neoplasm of brain
0.003 0.997 0.000
Q61.2 Polycystic kidney, adult type
0.003 0.997 0.000
H34.2 Other retinal artery occlusions
0.003 0.997 0.000
Y54.5 Other diuretics
0.003 0.997 0.000
G96.8 Other specified disorders of central nervous system
0.003 0.997 0.000
C71.1 Frontal lobe
0.003 0.997 0.000
C83.8 Other types of diffuse non-Hodgkin's lymphoma
0.000 0.997 0.003
Y54.1 Mineralocorticoid antagonists [aldosterone antagonists]
0.003 0.997 0.000
G25 Other extrapyramidal and movement disorders
0.003 0.997 0.000
G96 Other disorders of central nervous system
0.003 0.997 0.000
Y54 Agents primarily affecting water-balance and mineral and uric acid metabolism
0.003 0.997 0.000
G25.9 Extrapyramidal and movement disorder, unspecified
0.003 0.997 0.000
Y54.3 Benzothiadiazine derivatives
0.003 0.997 0.000
M15.00 Primary generalized (osteo)arthrosis, Multiple sites
0.003 0.997 0.000
C71.6 Cerebellum
0.003 0.997 0.000
R93.1 Abnormal findings on diagnostic imaging of heart and coronary circulation
0.000 0.997 0.003
X59.3 Sports and athletics area
0.003 0.997 0.000
Q61 Cystic kidney disease
0.003 0.997 0.000
H90.8 Mixed conductive and sensorineural hearing loss, unspecified
0.000 0.997 0.003
C91 Lymphoid leukaemia
0.000 0.997 0.003
C71.8 Overlapping lesion of brain
0.003 0.997 0.000
C71.4 Occipital lobe
0.003 0.997 0.000
H34.0 Transient retinal artery occlusion
0.002 0.997 0.000
T93.9 Sequelae of unspecified injury of lower limb
0.000 0.997 0.003
C16.0 Cardia
0.000 0.997 0.003
H34.9 Retinal vascular occlusion, unspecified
0.002 0.997 0.000
C91.0 Acute lymphoblastic leukaemia
0.000 0.997 0.003
X59 Exposure to unspecified factor
0.003 0.997 0.000
C91.9 Lymphoid leukaemia, unspecified
0.000 0.997 0.002
Y54.8 Agents affecting uric acid metabolism
0.002 0.997 0.000
C91.1 Chronic lymphocytic leukaemia
0.000 0.997 0.003
C71.5 Cerebral ventricle
0.002 0.997 0.000
H34.1 Central retinal artery occlusion
0.002 0.997 0.000
X59.2 School, other institution and public administrative area
0.002 0.997 0.000
Q61.4 Renal dysplasia
0.002 0.998 0.000
C71.7 Brain stem
0.002 0.998 0.000
R09.2 Respiratory arrest
0.000 0.998 0.002
Y54.4 Loop [high-ceiling] diuretics
0.002 0.998 0.000
H15.8 Other disorders of sclera
0.000 0.998 0.002
C71.2 Temporal lobe
0.002 0.998 0.000
I80.8 Phlebitis and thrombophlebitis of other sites
0.002 0.998 0.000
C83.9 Diffuse non-Hodgkin's lymphoma, unspecified
0.000 0.998 0.002
R06.1 Stridor
0.002 0.998 0.000
R61 Hyperhidrosis
0.000 0.998 0.002
G25.6 Drug-induced tics and other tics of organic origin
0.002 0.998 0.000
G25.4 Drug-induced chorea
0.002 0.998 0.000
G25.1 Drug-induced tremor
0.002 0.998 0.000
C83 Diffuse non-Hodgkin's lymphoma
0.000 0.998 0.002
G25.5 Other chorea
0.002 0.998 0.000
G96.9 Disorder of central nervous system, unspecified
0.002 0.998 0.000
Y54.9 Mineral salts, not elsewhere classified
0.002 0.998 0.000
Y54.6 Electrolytic, caloric and water-balance agents
0.002 0.998 0.000
Y54.2 Carbonic-anhydrase inhibitors
0.002 0.998 0.000
Y54.0 Mineralocorticoids
0.002 0.998 0.000
D12.7 Rectosigmoid junction
0.002 0.998 0.000
X59.4 Street and highway
0.002 0.998 0.000
Y54.7 Agents affecting calcification
0.002 0.998 0.000
X59.6 Industrial and construction area
0.002 0.998 0.000
C91.4 Hairy-cell leukaemia
0.000 0.998 0.002
F10.3 Withdrawal state
0.002 0.998 0.000
Q61.5 Medullary cystic kidney
0.002 0.998 0.000
Q61.8 Other cystic kidney diseases
0.002 0.998 0.000
Q61.1 Polycystic kidney, infantile type
0.002 0.998 0.000
C81-C96 Malignant neoplasms, stated or presumed to be primary, of lymphoid, haematopoietic and related tissue
0.000 0.998 0.002
N64.1 Fat necrosis of breast
0.002 0.998 0.000
C91.8 Mature B-cell leukaemia Burkitt-type
0.000 0.998 0.002
C91.7 Other lymphoid leukaemia
0.000 0.998 0.002
C91.6 Prolymphocytic leukaemia of T-cell type
0.000 0.998 0.002
C91.3 Prolymphocytic leukaemia
0.000 0.998 0.002
C91.2 Subacute lymphocytic leukaemia
0.000 0.998 0.002
S82.10 Fracture of upper end of tibia (closed)
0.000 0.998 0.002
I87.2 Venous insufficiency (chronic) (peripheral)
0.000 0.998 0.002
G63 Polyneuropathy in diseases classified elsewhere
0.000 0.998 0.002
C71.9 Brain, unspecified
0.002 0.998 0.000
X59.9 Unspecified place
0.002 0.998 0.000
X59.8 Other specified place
0.002 0.998 0.000
X59.0 Home
0.002 0.998 0.000
X59.7 Farm
0.002 0.998 0.000
X59.5 Trade and service area
0.002 0.998 0.000
X59.1 Residential institution
0.002 0.998 0.000
J35.8 Other chronic diseases of tonsils and adenoids
0.000 0.998 0.002
C71.0 Cerebrum, except lobes and ventricles
0.002 0.998 0.000
E11.4 With neurological complications
0.000 0.998 0.002
G25.2 Other specified forms of tremor
0.002 0.998 0.000
C91.5 Adult T-cell leukaemia
0.000 0.998 0.002
C92 Myeloid leukaemia
0.000 0.998 0.002
G96.1 Disorders of meninges, not elsewhere classified
0.002 0.998 0.000
Q61.9 Cystic kidney disease, unspecified
0.002 0.998 0.000
H15 Disorders of sclera
0.000 0.998 0.002
C69.9 Eye, unspecified
0.002 0.998 0.000
D68.5 Primary Thrombophilia
0.002 0.998 0.000
C88 Malignant immunoproliferative diseases
0.000 0.998 0.002
G90-G99 Other disorders of the nervous system
0.002 0.998 0.000
I87.8 Other specified disorders of veins
0.000 0.998 0.002
C83.6 Undifferentiated (diffuse)
0.000 0.998 0.002
C83.5 Lymphoblastic (diffuse)
0.000 0.998 0.002
C83.4 Immunoblastic (diffuse)
0.000 0.998 0.002
C83.2 Mixed small and large cell (diffuse)
0.000 0.998 0.002
C83.0 Small cell (diffuse)
0.000 0.998 0.002
N99.3 Prolapse of vaginal vault after hysterectomy
0.002 0.998 0.000
S82.00 Fracture of patella (closed)
0.000 0.998 0.002
H18.6 Keratoconus
0.000 0.998 0.002
N93.0 Postcoital and contact bleeding
0.002 0.998 0.000
C83.7 Burkitt's tumour
0.000 0.998 0.002
Q60-Q64 Congenital malformations of the urinary system
0.002 0.998 0.000
I87.1 Compression of vein
0.000 0.998 0.002
C96 Other and unspecified malignant neoplasms of lymphoid, haematopoietic and related tissue
0.000 0.998 0.002
C94 Other leukaemias of specified cell type
0.000 0.998 0.002
C86 Other specified types of T/NK-cell lymphoma
0.000 0.998 0.002
Y42 Hormones and their synthetic substitutes and antagonists, not elsewhere classified
0.002 0.998 0.000
C88.4 Extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue [MALT-lymphoma]
0.000 0.998 0.002
N70.9 Salpingitis and oophoritis, unspecified
0.002 0.998 0.000
H16.0 Corneal ulcer
0.000 0.998 0.002
O42.0 Premature rupture of membranes, onset of labour within 24 hours
0.000 0.998 0.002
Y42.8 Other and unspecified hormones and their synthetic substitutes
0.002 0.998 0.000
G63.8 Polyneuropathy in other diseases classified elsewhere
0.000 0.998 0.002
G63.6 Polyneuropathy in other musculoskeletal disorders
0.000 0.998 0.002
G63.5 Polyneuropathy in systemic connective tissue disorders
0.000 0.998 0.002
G63.4 Polyneuropathy in nutritional deficiency
0.000 0.998 0.002
G63.3 Polyneuropathy in other endocrine and metabolic diseases
0.000 0.998 0.002
G63.1 Polyneuropathy in neoplastic disease
0.000 0.998 0.002
G63.0 Polyneuropathy in infectious and parasitic diseases classified elsewhere
0.000 0.998 0.002
H19.3 Keratitis and keratoconjunctivitis in other diseases classified elsewhere
0.000 0.998 0.002
N90.5 Atrophy of vulva
0.002 0.998 0.000
Q63.0 Accessory kidney
0.002 0.998 0.000
R61.1 Generalised hyperhidrosis
0.000 0.998 0.002
M07.39 Other psoriatic arthropathies (Site unspecified)
0.000 0.998 0.002
X59.09 Exposure to unspecified factor causing fracture; Unspecified place;
0.002 0.998 0.000
X59.88 Exposure to unspecified factor; Other specified places ;While engaged in other specified activities
0.002 0.998 0.000
X59.99 Exposure to unspecified factor causing other and unspecified injury, Unspecified place
0.002 0.998 0.000
H15.1 Episcleritis
0.000 0.998 0.002
I87 Other disorders of veins
0.000 0.998 0.002
Q62 Congenital obstructive defects of renal pelvis and congenital malformations of ureter
0.002 0.998 0.000
C83.1 Small cleaved cell (diffuse)
0.000 0.998 0.002
H20.1 Chronic iridocyclitis
0.000 0.998 0.002
H90.5 Sensorineural hearing loss, unspecified
0.000 0.998 0.002
N64.9 Disorder of breast, unspecified
0.002 0.998 0.000
C95 Leukaemia of unspecified cell type
0.000 0.998 0.002
C16.6 Greater curvature of stomach, unspecified
0.000 0.998 0.002
G40.6 Grand mal seizures, unspecified (with or without petit mal)
0.002 0.998 0.000
G54.9 Nerve root and plexus disorder, unspecified
0.002 0.998 0.000
Q62.5 Duplication of ureter
0.002 0.998 0.000
H18 Other disorders of cornea
0.000 0.998 0.002
C92.9 Myeloid leukaemia, unspecified
0.000 0.998 0.002
C92.8 Acute myeloid leukaemia with multilineage dysplasia
0.000 0.998 0.002
C92.6 Acute myeloid leukaemia with 11q23-abnormality
0.000 0.998 0.002
C92.3 Myeloid sarcoma
0.000 0.998 0.002
C92.2 Subacute myeloid leukaemia
0.000 0.998 0.002
W22.5 Trade and service area
0.000 0.998 0.002
N64 Other disorders of breast
0.002 0.998 0.000
Q63 Other congenital malformations of kidney
0.002 0.998 0.000
H15.9 Disorder of sclera, unspecified
0.000 0.998 0.002
K70.9 Alcoholic liver disease, unspecified
0.002 0.998 0.000
T79.8 Other early complications of trauma
0.000 0.998 0.002
G25.3 Myoclonus
0.002 0.998 0.000
N64.5 Other signs and symptoms in breast
0.002 0.998 0.000
C93 Monocytic leukaemia
0.000 0.998 0.002
H15-H22 Disorders of sclera, cornea, iris and ciliary body
0.000 0.998 0.002
C88.9 Malignant immunoproliferative disease, unspecified
0.000 0.998 0.002
C88.7 Other malignant immunoproliferative diseases
0.000 0.998 0.002
C88.3 Immunoproliferative small intestinal disease
0.000 0.998 0.002
C88.2 Gamma heavy chain disease
0.000 0.998 0.002
C88.1 Alpha heavy chain disease
0.000 0.998 0.002
G92 Toxic encephalopathy
0.002 0.998 0.000
H16 Keratitis
0.000 0.998 0.002
M71.26 Synovial cyst of popliteal space [Baker]-Lower Leg
0.000 0.998 0.002
D03.3 Melanoma in situ of other and unspecified parts of face
0.002 0.998 0.000
M62.80 Other specified disorders of muscle (Multiple sites)
0.000 0.998 0.002
M77.91 Enthesopathy, unspecified (Shoulder region)
0.002 0.998 0.000
D89.9 Disorder involving the immune mechanism, unspecified
0.000 0.998 0.002
K51.8 Other ulcerative colitis
0.002 0.998 0.000
C95.9 Leukaemia, unspecified
0.000 0.998 0.002
E11.1 With ketoacidosis
0.002 0.998 0.000
H18.8 Other specified disorders of cornea
0.000 0.998 0.002
H18.5 Hereditary corneal dystrophies
0.000 0.998 0.002
I11.0 Hypertensive heart disease with (congestive) heart failure
0.000 0.998 0.002
K66.8 Other specified disorders of peritoneum
0.002 0.998 0.000
M62.8 Other specified disorders of muscle
0.000 0.998 0.002
H17 Corneal scars and opacities
0.000 0.998 0.002
M62.82 Other specified disorders of muscle (Upper arm)
0.000 0.998 0.002
H16.2 Keratoconjunctivitis
0.000 0.998 0.002
H22 Disorders of iris and ciliary body in diseases classified elsewhere
0.000 0.998 0.002
C86.6 Primary cutaneous CD30-positive T-cell proliferations
0.000 0.998 0.001
C86.5 Angioimmunoblastic T-cell lymphoma
0.000 0.998 0.001
C86.4 Blastic NK-cell lymphoma
0.000 0.998 0.001
C86.3 Subcutaneous panniculitis-like T-cell lymphoma
0.000 0.998 0.001
C86.2 Enteropathy-type (intestinal) T-cell lymphoma
0.000 0.998 0.001
C86.1 Hepatosplenic T-cell lymphoma
0.000 0.998 0.001
C86.0 Extranodal NK/T-cell lymphoma, nasal type
0.000 0.998 0.001
C92.7 Other myeloid leukaemia
0.000 0.998 0.001
C94.7 Other specified leukaemias
0.000 0.998 0.001
C94.6 Myelodysplastic and myeloproliferative disease, not elsewhere classified
0.000 0.998 0.001
C94.5 Acute myelofibrosis
0.000 0.998 0.001
C94.4 Acute panmyelosis
0.000 0.998 0.001
C94.3 Mast cell leukaemia
0.000 0.998 0.001
C94.2 Acute megakaryoblastic leukaemia
0.000 0.998 0.001
C94.1 Chronic erythraemia
0.000 0.998 0.001
C94.0 Acute erythraemia and erythroleukaemia
0.000 0.998 0.001
C96.9 Malignant neoplasms of lymphoid, haematopoietic and related tissue, unspecified
0.000 0.998 0.001
C96.8 Histiocytic sarcoma
0.000 0.998 0.001
C96.7 Other specified malignant neoplasms of lymphoid, haematopoietic and related tissue
0.000 0.998 0.001
C96.6 Unifocal Langerhans-cell histiocytosis
0.000 0.998 0.001
C96.5 Multifocal and unisystemic Langerhans-cell histiocytosis
0.000 0.998 0.001
C96.4 Sarcoma of dendritic cells (accessory cells)
0.000 0.998 0.001
C96.3 True histiocytic lymphoma
0.000 0.998 0.001
C96.2 Malignant mast cell tumour
0.000 0.998 0.001
C96.1 Malignant histiocytosis
0.000 0.998 0.001
C96.0 Letterer-Siwe disease
0.000 0.998 0.001
H16.1 Other superficial keratitis without conjunctivitis
0.000 0.998 0.002
V89.9 Person injured in unspecified vehicle accident
0.002 0.998 0.000
Y42.9 Other and unspecified hormone antagonists
0.001 0.998 0.000
Y42.4 Oral contraceptives
0.001 0.998 0.000
H19 Disorders of sclera and cornea in diseases classified elsewhere
0.000 0.998 0.002
M62.84 Other specified disorders of muscle (Hand)
0.000 0.998 0.002
C16.2 Body of stomach
0.000 0.998 0.002
C88.0 Waldenstrom's macroglobulinaemia
0.000 0.998 0.001
H22.1 Iridocyclitis in other diseases classified elsewhere
0.000 0.998 0.001
N94.3 Premenstrual tension syndrome
0.002 0.998 0.000
W18.5 Trade and service area
0.000 0.998 0.002
Z34.8 Supervision of other normal pregnancy
0.000 0.998 0.002
Q60 Renal agenesis and other reduction defects of kidney
0.002 0.998 0.000
M62.83 Other specified disorders of muscle (Forearm)
0.000 0.998 0.002
M62.81 Other specified disorders of muscle (Shoulder region)
0.000 0.998 0.002
B25.9 Cytomegaloviral disease, unspecified
0.000 0.998 0.002
H15.0 Scleritis
0.000 0.998 0.001
H35.4 Peripheral retinal degeneration
0.000 0.998 0.002
Q60.2 Renal agenesis, unspecified
0.001 0.998 0.000
R61.0 Localised hyperhidrosis
0.000 0.998 0.001
I87.0 Postphlebitic syndrome
0.000 0.998 0.001
O73.0 Retained placenta, without haemorrhage
0.002 0.998 0.000
Q62.8 Other congenital malformations of ureter
0.001 0.998 0.000
Q62.7 Congenital vesico-uretero-renal reflux
0.001 0.998 0.000
Q62.6 Malposition of ureter
0.001 0.998 0.000
Q62.4 Agenesis of ureter
0.001 0.998 0.000
Q62.3 Other obstructive defects of renal pelvis and ureter
0.001 0.998 0.000
Q62.2 Congenital megaloureter
0.001 0.998 0.000
Q62.1 Atresia and stenosis of ureter
0.001 0.998 0.000
Q62.0 Congenital hydronephrosis
0.001 0.998 0.000
W22.9 Unspecified place
0.000 0.998 0.002
X58.9 Unspecified place
0.001 0.998 0.000
Y52.4 Angiotensin-converting-enzyme inhibitors
0.000 0.998 0.002
Z71.3 Dietary counselling and surveillance
0.002 0.998 0.000
C16 Malignant neoplasm of stomach
0.000 0.998 0.002
X58 Exposure to other specified factors
0.001 0.998 0.000
X58-X59 Accidental exposure to other and unspecified factors
0.002 0.998 0.000
C95.7 Other leukaemia of unspecified cell type
0.000 0.998 0.001
C95.2 Subacute leukaemia of unspecified cell type
0.000 0.998 0.001
D21.2 Connective and other soft tissue of lower limb, including hip
0.002 0.998 0.000
H16.4 Corneal neovascularisation
0.000 0.998 0.001
I87.9 Disorder of vein, unspecified
0.000 0.998 0.001
Y42.2 Antithyroid drugs
0.001 0.998 0.000
Y42.1 Thyroid hormones and substitutes
0.001 0.998 0.000
Q64 Other congenital malformations of urinary system
0.001 0.998 0.000
H17.8 Other corneal scars and opacities
0.000 0.998 0.001
H18.7 Other corneal deformities
0.000 0.998 0.001
H18.2 Other corneal oedema
0.000 0.998 0.001
H20.0 Acute and subacute iridocyclitis
0.000 0.998 0.001
N99.8 Other postprocedural disorders of genito-urinary system
0.002 0.998 0.000
H20 Iridocyclitis
0.000 0.998 0.002
H17.9 Corneal scar and opacity, unspecified
0.000 0.998 0.001
N64.3 Galactorrhoea not associated with childbirth
0.001 0.998 0.000
N64.2 Atrophy of breast
0.001 0.998 0.000
N64.0 Fissure and fistula of nipple
0.001 0.998 0.000
Q63.9 Congenital malformation of kidney, unspecified
0.001 0.998 0.000
Q63.8 Other specified congenital malformations of kidney
0.001 0.998 0.000
Q63.3 Hyperplastic and giant kidney
0.001 0.998 0.000
G94 Other disorders of brain in diseases classified elsewhere
0.001 0.998 0.000
C92.5 Acute myelomonocytic leukaemia
0.000 0.998 0.001
C93.9 Monocytic leukaemia, unspecified
0.000 0.998 0.001
C93.7 Other monocytic leukaemia
0.000 0.998 0.001
C93.3 Juvenile myelomonocytic leukaemia
0.000 0.998 0.001
C93.2 Subacute monocytic leukaemia
0.000 0.998 0.001
C93.0 Acute monocytic leukaemia
0.000 0.998 0.001
G25.0 Essential tremor
0.001 0.998 0.000
G93.1 Anoxic brain damage, not elsewhere classified
0.001 0.998 0.000
H18.0 Corneal pigmentations and deposits
0.000 0.998 0.001
N99.1 Postprocedural urethral stricture
0.001 0.998 0.000
Q07.0 Arnold-Chiari syndrome
0.001 0.998 0.000
Y42.3 Insulin and oral hypoglycaemic [antidiabetic] drugs
0.001 0.998 0.000
Y52.1 Calcium-channel blockers
0.000 0.998 0.001
C84 Peripheral and cutaneous T-cell lymphomas
0.000 0.998 0.001
G98 Other disorders of nervous system, not elsewhere classified
0.001 0.998 0.000
C22.9 Liver, unspecified
0.000 0.998 0.001
C25.0 Head of pancreas
0.000 0.998 0.001
L08.8 Other specified local infections of skin and subcutaneous tissue
0.001 0.998 0.000
Q64.4 Malformation of urachus
0.001 0.998 0.000
Y52.3 Coronary vasodilators, not elsewhere classified
0.000 0.998 0.001
H18.3 Changes in corneal membranes
0.000 0.999 0.001
K70.4 Alcoholic hepatic failure
0.001 0.999 0.000
R10.2 Pelvic and perineal pain
0.001 0.999 0.000
R57.2 Septic shock
0.001 0.999 0.000
C69 Malignant neoplasm of eye and adnexa
0.001 0.999 0.000
M62.88 Other specified disorders of muscle (Other)
0.000 0.999 0.001
M62.87 Other specified disorders of muscle (Ankle and foot)
0.000 0.999 0.001
C95.1 Chronic leukaemia of unspecified cell type
0.000 0.999 0.001
H17.1 Other central corneal opacity
0.000 0.999 0.001
H17.0 Adherent leukoma
0.000 0.999 0.001
Q63.1 Lobulated, fused and horseshoe kidney
0.001 0.999 0.000
C92.4 Acute promyelocytic leukaemia
0.000 0.999 0.001
D86.0 Sarcoidosis of lung
0.000 0.999 0.001
H22.8 Other disorders of iris and ciliary body in diseases classified elsewhere
0.000 0.999 0.001
H22.0 Iridocyclitis in infectious and parasitic diseases classified elsewhere
0.000 0.999 0.001
C69-C72 Malignant neoplasms of eye, brain and other parts of central nervous system
0.001 0.999 0.000
M24.54 Contracture of joint (Hand)
0.001 0.999 0.000
M62.89 Other specified disorders of muscle (Site unspecified)
0.000 0.999 0.001
M62.85 Other specified disorders of muscle (Pelvic region and thigh)
0.000 0.999 0.001
C84.4 Peripheral T-cell lymphoma
0.000 0.999 0.001
G71.3 Mitochondrial myopathy, not elsewhere classified
0.000 0.999 0.001
H19.8 Other disorders of sclera and cornea in diseases classified elsewhere
0.000 0.999 0.001
H19.0 Scleritis and episcleritis in diseases classified elsewhere
0.000 0.999 0.001
C16.3 Pyloric antrum
0.000 0.999 0.001
C95.0 Acute leukaemia of unspecified cell type
0.000 0.999 0.001
H16.8 Other keratitis
0.000 0.999 0.001
I80.3 Phlebitis and thrombophlebitis of lower extremities, unspecified
0.001 0.999 0.000
Q60.6 Potter's syndrome
0.001 0.999 0.000
Q60.5 Renal hypoplasia, unspecified
0.001 0.999 0.000
Q60.4 Renal hypoplasia, bilateral
0.001 0.999 0.000
Q60.3 Renal hypoplasia, unilateral
0.001 0.999 0.000
Q60.1 Renal agenesis, bilateral
0.001 0.999 0.000
M62.86 Other specified disorders of muscle (Lower leg)
0.000 0.999 0.001
C16.8 Overlapping lesion of stomach
0.000 0.999 0.001
L43.8 Other lichen planus
0.001 0.999 0.000
N64.8 Other specified disorders of breast
0.001 0.999 0.000
X58.8 Other specified place
0.001 0.999 0.000
X58.0 Home
0.001 0.999 0.000
X58.7 Farm
0.001 0.999 0.000
X58.6 Industrial and construction area
0.001 0.999 0.000
X58.5 Trade and service area
0.001 0.999 0.000
X58.4 Street and highway
0.001 0.999 0.000
X58.3 Sports and athletics area
0.001 0.999 0.000
X58.2 School, other institution and public administrative area
0.001 0.999 0.000
X58.1 Residential institution
0.001 0.999 0.000
M90.78 Fracture of bone in neoplastic disease (Other)
0.000 0.999 0.001
C16.4 Pylorus
0.000 0.999 0.001
C45.0 Mesothelioma of pleura
0.000 0.999 0.001
H20.2 Lens-induced iridocyclitis
0.000 0.999 0.001
Q64.9 Congenital malformation of urinary system, unspecified
0.001 0.999 0.000
Q64.8 Other specified congenital malformations of urinary system
0.001 0.999 0.000
Q64.7 Other congenital malformations of bladder and urethra
0.001 0.999 0.000
Q64.6 Congenital diverticulum of bladder
0.001 0.999 0.000
Q64.5 Congenital absence of bladder and urethra
0.001 0.999 0.000
Q64.2 Congenital posterior urethral valves
0.001 0.999 0.000
Q64.1 Exstrophy of urinary bladder
0.001 0.999 0.000
Q64.0 Epispadias
0.001 0.999 0.000
R09.8 Other specified symptoms and signs involving the circulatory and respiratory systems
0.000 0.999 0.001
Y42.6 Antigonadotrophins, antioestrogens, antiandrogens, not elsewhere classified
0.001 0.999 0.000
W22 Striking against or struck by other objects
0.000 0.999 0.001
Y52 Agents primarily affecting the cardiovascular system
0.000 0.999 0.001
G94.8 Other specified disorders of brain in diseases classified elsewhere
0.001 0.999 0.000
G94.0 Hydrocephalus in infectious and parasitic diseases classified elsewhere
0.001 0.999 0.000
H18.9 Disorder of cornea, unspecified
0.000 0.999 0.001
K70.0 Alcoholic fatty liver
0.001 0.999 0.000
Y52.9 Other and unspecified agents primarily affecting the cardiovascular system
0.000 0.999 0.001
M25.66 Stiffness of joint, not elsewhere classified (Lower leg)
0.001 0.999 0.000
C84.9 Mature T/NK-cell lymphoma, unspecified
0.000 0.999 0.001
C84.8 Cutaneous T-cell lymphoma, unspecified
0.000 0.999 0.001
C84.7 Anaplastic large cell lymphoma, ALK-negative
0.000 0.999 0.001
C84.6 Anaplastic large cell lymphoma, ALK-positive
0.000 0.999 0.001
C84.3 Lymphoepithelioid lymphoma
0.000 0.999 0.001
C84.2 T-zone lymphoma
0.000 0.999 0.001
C84.1 Sezary's diease
0.000 0.999 0.001
G94.2 Hydrocephalus in other diseases classified elsewhere
0.001 0.999 0.000
L29.9 Pruritus, unspecified
0.001 0.999 0.000
Q63.2 Ectopic kidney
0.001 0.999 0.000
W22.2 School, other institution and public administrative area
0.000 0.999 0.001
C69.8 Overlapping lesion of eye and adnexa
0.001 0.999 0.000
C69.6 Orbit
0.001 0.999 0.000
C69.5 Lachrymal gland and duct
0.001 0.999 0.000
C69.4 Ciliary body
0.001 0.999 0.000
C69.2 Retina
0.001 0.999 0.000
C69.1 Cornea
0.001 0.999 0.000
C93.1 Chronic monocytic leukaemia
0.000 0.999 0.001
D89.2 Hypergammaglobulinaemia, unspecified
0.000 0.999 0.001
G93.0 Cerebral cysts
0.001 0.999 0.000
H16.3 Interstitial and deep keratitis
0.000 0.999 0.001
H19.2 Keratitis and keratoconjunctivitis in other infectious and parasitic diseases classified elsewhere
0.000 0.999 0.001
I11.9 Hypertensive heart disease without (congestive) heart failure
0.000 0.999 0.001
Q28.0 Arteriovenous malformation of precerebral vessels
0.001 0.999 0.000
N83.2 Other and unspecified ovarian cysts
0.001 0.999 0.000
V09.1 Pedestrian injured in unspecified nontraffic accident
0.001 0.999 0.000
Y52.6 Antihyperlipidaemic and antiarteriosclerotic drugs
0.000 0.999 0.001
C43.4 Malignant melanoma of scalp and neck
0.001 0.999 0.000
H18.4 Corneal degeneration
0.000 0.999 0.001
N64.4 Mastodynia
0.001 0.999 0.000
R09.0 Asphyxia
0.000 0.999 0.001
D89 Other disorders involving the immune mechanism, not elsewhere classified
0.000 0.999 0.001
N99 Postprocedural disorders of genito-urinary system, not elsewhere classified
0.001 0.999 0.000
C16.1 Fundus of stomach
0.000 0.999 0.001
H02.0 Entropion and trichiasis of eyelid
0.000 0.999 0.001
T40.4 Other synthetic narcotics
0.001 0.999 0.000
Q07 Other congenital malformations of nervous system
0.001 0.999 0.000
M85.85 Other specified disorders of bone density and structure (Pelvic region and thigh)
0.001 0.999 0.000
X58.01 Exposure to other specified factors: Home: While engaged in leisure activity
0.001 0.999 0.000
X58.89 Exposure to other specified factors: Other specified places: During unspecified activity
0.001 0.999 0.000
C16.5 Lesser curvature of stomach, unspecified
0.000 0.999 0.001
H18.1 Bullous keratopathy
0.000 0.999 0.001
K70.3 Alcoholic cirrhosis of liver
0.001 0.999 0.000
N75.1 Abscess of Bartholin's gland
0.000 0.999 0.001
Q61.0 Congenital single renal cyst
0.001 0.999 0.001
S20.8 Superficial injuries of other and unspecified parts of thorax
0.001 0.999 0.000
W22.8 Other specified place
0.000 0.999 0.001
W22.6 Industrial and construction area
0.000 0.999 0.001
W22.4 Street and highway
0.000 0.999 0.001
W22.0 Home
0.000 0.999 0.001
W22.7 Farm
0.000 0.999 0.001
W22.1 Residential institution
0.000 0.999 0.001
Y52.8 Antivaricose drugs, including sclerosing agents
0.000 0.999 0.001
Y52.7 Peripheral vasodilators
0.000 0.999 0.001
K11.6 Mucocele of salivary gland
0.000 0.999 0.001
W22.3 Sports and athletics area
0.000 0.999 0.001
D89.0 Polyclonal hypergammaglobulinaemia
0.000 0.999 0.001
G50.8 Other disorders of trigeminal nerve
0.000 0.999 0.001
H19.1 Herpesviral keratitis and keratoconjunctivitis
0.000 0.999 0.001
I80.1 Phlebitis and thrombophlebitis of femoral vein
0.001 0.999 0.000
R09.3 Abnormal sputum
0.000 0.999 0.001
C72 Malignant neoplasm of spinal cord, cranial nerves and other parts of central nervous system
0.001 0.999 0.000
G50 Disorders of trigeminal nerve
0.000 0.999 0.001
J81 Pulmonary oedema
0.001 0.999 0.000
K70 Alcoholic liver disease
0.001 0.999 0.000
R09 Other symptoms and signs involving the circulatory and respiratory systems
0.000 0.999 0.001
D86.8 Sarcoidosis of other and combined sites
0.000 0.999 0.001
Q07.8 Other specified congenital malformations of nervous system
0.001 0.999 0.000
Y52.0 Cardiac-stimulant glycosides and drugs of similar action
0.000 0.999 0.001
Y79.2 Prosthetic and other implants, materials and accessory devices
0.001 0.999 0.000
C70 Malignant neoplasm of meninges
0.001 0.999 0.000
M24.15 Other articular cartilage disorders (Pelvic region and thigh)
0.001 0.999 0.000
D89.8 Other specified disorders involving the immune mechanism, not elsewhere classified
0.000 0.999 0.001
D89.3 Immune reconstitution syndrome
0.000 0.999 0.001
D89.1 Cryoglobulinaemia
0.000 0.999 0.001
G50.9 Disorder of trigeminal nerve, unspecified
0.000 0.999 0.001
Y52.2 Other antidysrhythmic drugs, not elsewhere classified
0.000 0.999 0.001
C84.0 Mycosis fungoides
0.000 0.999 0.001
D38.1 Trachea, bronchus and lung
0.001 0.999 0.000
Q07.9 Congenital malformation of nervous system, unspecified
0.001 0.999 0.000
Q28.2 Arteriovenous malformation of cerebral vessels
0.001 0.999 0.000
Y42.0 Glucocorticoids and synthetic analogs
0.001 0.999 0.000
G71 Primary disorders of muscles
0.000 0.999 0.001
W22.09 Striking against or struck by other objects; Home; During unspecified activity
0.000 0.999 0.001
W22.03 Striking against or struck by other objects; Home; While engaged in other types of work
0.000 0.999 0.001
W22.41 Striking against or struck by other objects; Street and highway;While engaged in leisure activity
0.000 0.999 0.001
W22.62 Striking against or struck by other objects; Industrial and construction area ;While working for income
0.000 0.999 0.001
W22.88 Striking against or struck by other objects; Other specified places ;While engaged in other specified activities
0.000 0.999 0.001
G71.1 Myotonic disorders
0.000 0.999 0.001
G71.0 Muscular dystrophy
0.000 0.999 0.001
Q64.3 Other atresia and stenosis of urethra and bladder neck
0.001 0.999 0.000
W08.0 Home
0.000 0.999 0.001
C69.0 Conjunctiva
0.001 0.999 0.000
C70.9 Meninges, unspecified
0.001 0.999 0.000
C70.1 Spinal meninges
0.001 0.999 0.000
C72.9 Central nervous system, unspecified
0.001 0.999 0.000
C72.8 Overlapping lesion of brain and other parts of central nervous system
0.001 0.999 0.000

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.